Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.686 USD | -0.50% | +4.53% | -36.04% |
05-20 | Entero Therapeutics, Inc.(NasdaqCM:ENTO) added to NASDAQ Composite Index | CI |
05-17 | First Wave BioPharma, Inc. will Change its Name to Entero Therapeutics, Inc | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.04% | 6.68M | |
+49.20% | 54.63B | |
-4.57% | 39.92B | |
+37.18% | 38.82B | |
+16.05% | 26.86B | |
-12.56% | 26.22B | |
-21.89% | 18.78B | |
+25.78% | 12.21B | |
+2.30% | 12.16B | |
+27.03% | 11.94B |
- Stock Market
- Equities
- ENTO Stock
- News Entero Therapeutics, Inc.
- AzurRx BioPharma : Roth Capital Adjusts Price Target on AzurRx BioPharma to $5 From $7, Maintains Buy Rating